Oncopeptides AB (publ) (STO: ONCO)
Sweden
· Delayed Price · Currency is SEK
2.210
+0.035 (1.61%)
Aug 30, 2024, 5:29 PM CET
Oncopeptides AB Revenue
Oncopeptides AB had revenue of -1.00K SEK in the twelve months ending June 30, 2024, down -100.02% year-over-year. In the year 2023, Oncopeptides AB had annual revenue of 721.00K, down -94.37%.
Revenue (ttm)
-1.00K
Revenue Growth
-100.02%
P/S Ratio
22.25
Revenue / Employee
318.94K
Employees
57
Market Cap
475.56M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
ABB Ltd | 342.58B |
Investor AB (publ) | 240.73B |
Investor AB (publ) | 240.73B |
Atlas Copco AB | 177.12B |
Atlas Copco AB | 177.12B |
AB Volvo (publ) | 552.20B |
AB Volvo (publ) | 552.20B |
Oncopeptides AB News
- 17 days ago - Oncopeptides AB (OSTO:ONCO) Q2 2024 Earnings Call Transcript Highlights: Revenue Surge and ... - GuruFocus
- 17 days ago - Q2 2024 Oncopeptides AB Earnings Call Transcript - GuruFocus